Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503. Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503. Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609. Podcast Aug 2020 Ethics Talk: The Ongoing Opioid Epidemic Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. AMA Code Says Oct 2012 AMA Code of Medical Ethics’ Opinion on Confidential Services for Children and Adolescents AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics' opinions on confidential services for children and adolescents. Virtual Mentor. 2012;14(10):778-779. doi: 10.1001/virtualmentor.2012.14.10.coet1-1210. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary May 2020 How Should Adolescent Health Decision-Making Authority Be Shared? Kimberly Sawyer, MD and Abby R. Rosenberg, MD, MS, MA Shared decision making is complex with patients who are adolescents, whose relational autonomy is still emerging. AMA J Ethics. 2020;22(5):E372-379. doi: 10.1001/amajethics.2020.372.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503.
Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503.
Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609.
Podcast Aug 2020 Ethics Talk: The Ongoing Opioid Epidemic Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
AMA Code Says Oct 2012 AMA Code of Medical Ethics’ Opinion on Confidential Services for Children and Adolescents AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics' opinions on confidential services for children and adolescents. Virtual Mentor. 2012;14(10):778-779. doi: 10.1001/virtualmentor.2012.14.10.coet1-1210.